The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Open Access
- 28 February 2024
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 1-8
Abstract
Background: Airway epithelial cells (AECs) are a major component of local airway immune responses. Direct effects of type 2 cytokines on AECs are implicated in type 2 asthma, which is driven by epithelial-derived cytokines and leads to airway obstruction. However, evidence suggests that restoring epithelial health may attenuate asthmatic features. Methods: We investigated the effects of passive sensitisation on IL-5, NF-κB, HDAC-2, ACh, and ChAT in human bronchial epithelial cells (HBEpCs) and the effects of fluticasone furoate (FF) and umeclidinium (UME) alone and in combination on these responses. Results: IL-5 and NF-κB levels were increased, and that of HDAC-2 reduced in sensitised HEBpCs. Pretreatment with FF reversed the effects of passive sensitisation by concentration-dependent reduction of IL-5, resulting in decreased NF-κB levels and restored HDAC-2 activity. Addition of UME enhanced these effects. Sensitized HEBpCs also exhibited higher ACh and ChAT levels. Pretreatment with UME significantly reduced ACh levels, and addition of FF caused a further small reduction. Conclusion: This study confirmed that passive sensitisation of AECs results in an inflammatory response with increased levels of IL-5 and NF-κB, reduced levels of HDAC-2, and higher levels of ACh and ChAT compared to normal cells. Combining FF and UME was found to be more effective in reducing IL-5, NF-κB, and ACh and restoring HDAC-2 compared to the individual components. This finding supports adding a LAMA to established ICS/LABA treatment in asthma and suggests the possibility of using an ICS/LAMA combination when needed.Keywords
Funding Information
- GlaxoSmithKline (Study 214746)
This publication has 37 references indexed in Scilit:
- Defective epithelial barrier function in asthmaJournal of Allergy and Clinical Immunology, 2011
- Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthmaClinical & Experimental Allergy, 2010
- Histone deacetylase-2 and airway diseaseTherapeutic Advances in Respiratory Disease, 2009
- Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparisonEuropean Respiratory Journal, 2007
- Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparationsEuropean Journal of Pharmacology, 2006
- Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppressionJournal of Experimental Medicine, 2005
- Passive sensitization of human airways increases responsiveness to leukotriene C4European Respiratory Journal, 1999
- Glucocorticoids mediate reduction of epithelial acetylcholine content in the airways of rats and humansEuropean Journal of Pharmacology, 1998
- Incubation With IgE Increases Cholinergic Neurotransmission in Human Airways in VitroAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Increased acetylcholine release in tracheas from allergen-exposed IgE-immune miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1994